Compare BridgeBio Pharma Inc (BBIO) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Xcel Energy Inc — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Xcel Energy Inc trades at $77.66 (market cap $48.51B). The key difference: Xcel Energy Inc is far larger — about 3× BridgeBio Pharma Inc's market cap, and Xcel Energy Inc pays a 3.05% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | XEL | |
|---|---|---|
Market Cap | $16.36B | $48.51B |
Sector | Health | Utilities |
52-Week High | $90.17 | $83.91 |
52-Week Low | $47.29 | $71.75 |
Enterprise Value | $18.14B | $86.82B |
Dividend Yield | — | 3.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
